Status:
COMPLETED
Peri-Articular-Multimodal Drug and Oral Celecoxib in Management of Postoperative Pain of Total Knee Arthroplasty
Lead Sponsor:
Isfahan University of Medical Sciences
Conditions:
Postoperative Pain
Total Knee Arthroplasty
Eligibility:
All Genders
37-81 years
Phase:
PHASE2
Brief Summary
This study is a randomized-clinical-trial on 146 patients candidate for total knee arthroplasty (TKA) who were randomly allocated to three treatment groups, including 1) a cocktail consisting of bupiv...
Detailed Description
This randomized clinical trial conducted on 146 patients undergone TKA in orthopedic hospitals affiliated at Isfahan University of Medical Science (IUMS) in 2021. The presence of osteoarthritis, maki...
Eligibility Criteria
Inclusion
- Clinical diagnosis of osteoarthritis
- Candidate for primary unilateral TKA
- Body mass index of 20-30 kg/m2
Exclusion
- Unable to follow-up the assessments
- Having more than 20% defects in medical records
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT05324995
Start Date
January 1 2021
End Date
March 1 2022
Last Update
April 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Isfahan University of Medical Sciences
Isfahan, Iran